Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
Wenxia Zhao, Mengyan Wang, Meilian Cai, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110956-110956
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
Reyhaneh Farghadani, Rakesh Naidu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115170-115170
Open Access | Times Cited: 44
The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
Ιωάννα Ακρίδα, Vasiliki Bravou, Helen Papadaki
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 10065-10076
Closed Access | Times Cited: 45
TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Ran Hu, Yu Cao, Yuanyuan Wang, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 8
YAP/TAZ: Molecular pathway and disease therapy
Yuzi Wei, Victoria Lee Zhi Hui, Yilin Chen, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 18
HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity
Bo Yuan, Jinquan Liu, Aiping Shi, et al.
The EMBO Journal (2023) Vol. 42, Iss. 4
Closed Access | Times Cited: 17
Insight into the differential toxicity of PFOA and PFBA based on a 3D-cultured MDA-MB-231 cell model
Huan Wang, Hongchang Zhang, Shuangqing Hu, et al.
Journal of Hazardous Materials (2024) Vol. 465, pp. 133499-133499
Closed Access | Times Cited: 4
Despicable role of epithelial–mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens
Paras Famta, Saurabh Shah, Biswajit Dey, et al.
Cancer Pathogenesis and Therapy (2024) Vol. 3, Iss. 1, pp. 30-47
Open Access | Times Cited: 4
Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges
Zeeshan Ahmad Bhutta, Kyung‐Chul Choi
Archives of Pharmacal Research (2025)
Closed Access
Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
MED12 dysregulation: insights into cancer and therapeutic resistance
Ritesh P. Bhole, Jagruti Shinkar, Sonali Labhade, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics
Gangyin Zhao, Ye Zeng, Wanli Cheng, et al.
ACS Nano (2025)
Closed Access
Mammary stem cells: molecular cues, orchestrated regulatory mechanisms and its implications in breast cancer
Mengna Zhang, Lingxian Zhang, Jie Liu, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2025)
Closed Access
The Hippo Pathway: A Master Regulatory Network Important in Cancer
Qiuping Liu, Xiaomeng Liu, Guanbin Song
Cells (2021) Vol. 10, Iss. 6, pp. 1416-1416
Open Access | Times Cited: 23
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer
Sahar Sarmasti Emami, Anni Ge, Derek Zhang, et al.
(2024)
Open Access | Times Cited: 2
Breast Cancer: Circular RNAs Mediating Efficacy in PreclinicalIn VivoModels
Ulrich H. Weidle, Hung‐En Hsia, Ulrich Brinkmann
Cancer Genomics & Proteomics (2023) Vol. 20, Iss. 3, pp. 222-238
Open Access | Times Cited: 6
Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer
Tongyao Yu, Ge Zhang, Xiaoxia Chai, et al.
Life Sciences (2023) Vol. 332, pp. 122084-122084
Closed Access | Times Cited: 6
Single-cell sequencing reveals the antifibrotic effects of YAP/TAZ in systemic sclerosis
Dongke Wu, Wei Wang, Xinyue Li, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 149, pp. 106257-106257
Closed Access | Times Cited: 9
Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis
Mohsin Ahmad Ghauri, Ali Raza, Uzma Hayat, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2022) Vol. 1866, Iss. 5, pp. 130113-130113
Closed Access | Times Cited: 8
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer
Sahar Sarmasti Emami, Anni Ge, Derek Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4064-4064
Open Access | Times Cited: 1
Role of Yes-Associated Protein in Psoriasis and Skin Tumor Pathogenesis
Jinjing Jia, Yuqian Wang, Xiumei Mo, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 978-978
Open Access | Times Cited: 6
Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies
Rama Rao Malla, Durga Bhavani Kundrapu, Priyamvada Bhamidipati, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5728-5728
Open Access | Times Cited: 3
OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma
Li Liu, Cheng Hu, Min Ji, et al.
Biological Procedures Online (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
Jing Chen, Runlan Wan, Qinqin Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway
Abdelhalim Azzi, Zhipeng Tao, Yang Sun, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107449-107449
Open Access | Times Cited: 2
HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells
Yangying Hu, Deqi Wu, Rong Huang, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top